Both of these cancers are characterized by a high cellular heterogeneity, with a constitutive CD133+/CD15+ (stage specific embryonic antigen 1, SSEA-1) neural CSC subpopulation feeding the bulk tumor [71,223,224,225]. The gene discussed is FUT4; the disease is neoplasm.